Genetic Analysis AS Statistics

Total Valuation

XSAT:GEAN has a market cap or net worth of SEK 45.00 million. The enterprise value is 28.12 million.

Market Cap	45.00M
Enterprise Value	28.12M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

XSAT:GEAN has 69.09 million shares outstanding. The number of shares has increased by 54.37% in one year.

Current Share Class	69.09M
Shares Outstanding	69.09M
Shares Change (YoY)	+54.37%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.71%
Owned by Institutions (%)	14.91%
Float	20.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.32
PB Ratio	1.82
P/TBV Ratio	3.32
P/FCF Ratio	24.02
P/OCF Ratio	20.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.69
EV / Sales	1.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.01

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.24.

Current Ratio	1.64
Quick Ratio	1.60
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	3.12
Interest Coverage	-22.71

Financial Efficiency

Return on equity (ROE) is -46.05% and return on invested capital (ROIC) is -21.38%.

Return on Equity (ROE)	-46.05%
Return on Assets (ROA)	-14.85%
Return on Invested Capital (ROIC)	-21.38%
Return on Capital Employed (ROCE)	-33.65%
Weighted Average Cost of Capital (WACC)	15.49%
Revenue Per Employee	1.21M
Profits Per Employee	-652,215
Employee Count	16
Asset Turnover	0.45
Inventory Turnover	6.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.85% in the last 52 weeks. The beta is 2.26, so XSAT:GEAN's price volatility has been higher than the market average.

Beta (5Y)	2.26
52-Week Price Change	-6.85%
50-Day Moving Average	0.70
200-Day Moving Average	0.83
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	40,424

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:GEAN had revenue of SEK 19.36 million and -10.44 million in losses. Loss per share was -0.16.

Revenue	19.36M
Gross Profit	15.06M
Operating Income	-10.30M
Pretax Income	-10.44M
Net Income	-10.44M
EBITDA	-5.57M
EBIT	-10.30M
Loss Per Share	-0.16

Full Income Statement

Balance Sheet

The company has 21.97 million in cash and 5.85 million in debt, giving a net cash position of 16.12 million or 0.23 per share.

Cash & Cash Equivalents	21.97M
Total Debt	5.85M
Net Cash	16.12M
Net Cash Per Share	0.23
Equity (Book Value)	24.76M
Book Value Per Share	0.36
Working Capital	11.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.20 million and capital expenditures -321,850, giving a free cash flow of 1.87 million.

Operating Cash Flow	2.20M
Capital Expenditures	-321,850
Free Cash Flow	1.87M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 77.80%, with operating and profit margins of -53.21% and -53.91%.

Gross Margin	77.80%
Operating Margin	-53.21%
Pretax Margin	-53.91%
Profit Margin	-53.91%
EBITDA Margin	-28.77%
EBIT Margin	-53.21%
FCF Margin	9.68%

Dividends & Yields

XSAT:GEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.37%
Shareholder Yield	-54.37%
Earnings Yield	-23.19%
FCF Yield	4.16%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:GEAN has an Altman Z-Score of 0.45 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.45
Piotroski F-Score	4